Personalised Cancer Treatment Plans: From Genetic Testing to Precision Intervention
Making every step of treatment truly targeted to your tumour
In the past, cancer treatment was often “one-size-fits-all”:
patients with the same type of lung, breast, or colorectal cancer received largely similar protocols.
But growing evidence shows that every tumour has a unique genetic expression, signalling pathways, and drug response — as individual as a fingerprint.
Personalised treatment plans have emerged to shift care from “generally effective” to “precisely targeted”.
Starting with genetic testing to understand your tumour’s “personality”
Conventional NGS genetic testing can identify “which mutations are present”,
but cannot reveal “how important that mutation is right now” or “which drugs the tumour is truly sensitive to”.
This is where advanced functional testing comes in — asking live tumour cells directly: “What do you fear most at this moment?”
RGCC Onconomics Plus® is currently one of the most comprehensive “tumour functional sensitivity tests” internationally:
a single blood draw provides:
- Real sensitivity and resistance profile against 50+ conventional chemotherapy, targeted, and immunotherapy agents
- Inhibitory effects against 30+ natural compounds (curcumin, Reishi polysaccharide, silymarin, quercetin, high-dose vitamin C, etc.)
- Dominant signalling pathways currently driving tumour growth and metastasis
- Clear identification of ineffective or low-efficacy drugs, avoiding unnecessary toxicity
- Selection of natural supportive agents showing high activity against your specific tumour
With this 100 % customised “tumour weakness map”,
your physician can design the most fitting plan from the outset:
- Selecting the drug combinations most likely to work, reducing trial-and-error
- Avoiding agents your tumour is completely resistant to, minimising side effects
- Incorporating natural compounds with proven inhibitory effect on your tumour to enhance overall efficacy
- Monitoring changes in tumour sensitivity during treatment for timely adjustments
Who may particularly benefit from considering a personalised approach
- Patients with limited response to standard therapy or concerned about excessive side effects
- Complex cases with rare mutations or multiple resistance
- Those wishing to integrate scientifically validated natural support alongside conventional care
- Anyone seeking treatment decisions backed by more evidence and less guesswork
Summary
The core of personalised cancer treatment
is not “using the most expensive or newest drugs”,
but “using the drugs and supportive agents most effective against your specific tumour”.
From genetic testing to precision intervention, every step is built on truly understanding your tumour,
resulting in better efficacy, fewer side effects, and improved quality of life.
If you would like to know how sensitive your tumour is to conventional drugs and natural compounds,
please feel welcome to contact us at any time.
Our integrative oncology team will arrange RGCC Onconomics Plus® testing followed by a detailed one-to-one specialist interpretation,
helping you develop the most precise and compassionate personalised treatment plan.
You deserve every treatment decision to be as individual as your tumour.
Disclaimer：
The information provided in this article is for educational and informational purposes only. It is not intended to diagnose, treat, cure, or prevent any disease, nor should it replace professional medical advice. Readers are encouraged to consult with a qualified healthcare provider or integrative oncology specialist before making any changes to their diet, treatment plan, or lifestyle based on the content herein. Therapies and tests mentioned, including immune or integrative treatments, should always be…
All product names, test references, and therapy mentions are for informational context only and do not constitute endorsement. Results and experiences may vary among individuals.